Home LiteratureArticle Details
PMID: 11927610 Published · ppublish English Journal Article Review

Mixed signals in heart failure: cancer rules.

The Journal of clinical investigation ·Vol. 109 ·No. 7 ·2002-04-00 ·Pages 849-55

Hoshijima M, Chien KR

Abstract

暂无摘要

MeSH Terms
Animals Disease Progression Heart Failure/genetics,metabolism Humans Proto-Oncogene Proteins/genetics,metabolism Signal Transduction
Chemicals
Proto-Oncogene Proteins
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Hoshijima Masahiko
University of California, San Diego (UCSD) Institute of Molecular Medicine, UCSD-Salk Program in Molecular Medicine, La Jolla, California 92093, USA.
Chien Kenneth R
References (48)
48 references, click to expand
  1. CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo.
    J Clin Invest. 2000 May;105(10):1395-406 PMID: 10811847
  2. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
    N Engl J Med. 2001 Jun 14;344(24):1823-31 PMID: 11407343
  3. Abnormalities of calcium cycling in the hypertrophied and failing heart.
    J Mol Cell Cardiol. 2000 Sep;32(9):1595-607 PMID: 10966823
  4. Genetics of heart development.
    Trends Genet. 2000 Sep;16(9):383-8 PMID: 10973066
  5. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation.
    Nat Genet. 2001 Jul;28(3):276-80 PMID: 11431700
  6. Calcineurin plays a critical role in the development of pressure overload-induced cardiac hypertrophy.
    Circulation. 2001 Jul 3;104(1):97-101 PMID: 11435345
  7. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor.
    Cell. 2001 Jun 29;105(7):851-62 PMID: 11439182
  8. Cardiac gene delivery with cardiopulmonary bypass.
    Circulation. 2001 Jul 10;104(2):131-3 PMID: 11447073
  9. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease.
    Cell. 2001 Sep 21;106(6):709-21 PMID: 11572777
  10. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes.
    Nat Med. 2001 Nov;7(11):1236-40 PMID: 11689889
  11. Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system.
    J Mol Biol. 2001 Nov 2;313(4):775-84 PMID: 11697903
  12. Suppressor of cytokine signaling-3 is a biomechanical stress-inducible gene that suppresses gp130-mediated cardiac myocyte hypertrophy and survival pathways.
    J Clin Invest. 2001 Nov;108(10):1459-67 PMID: 11714737
  13. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways.
    Nat Cell Biol. 2001 Nov;3(11):1009-13 PMID: 11715022
  14. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo.
    Nat Cell Biol. 2001 Nov;3(11):1014-9 PMID: 11715023
  15. A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia.
    Cell. 2001 Dec 14;107(6):801-13 PMID: 11747815
  16. Requirement of a macromolecular signaling complex for beta adrenergic receptor modulation of the KCNQ1-KCNE1 potassium channel.
    Science. 2002 Jan 18;295(5554):496-9 PMID: 11799244
  17. Cardiac excitation-contraction coupling.
    Nature. 2002 Jan 10;415(6868):198-205 PMID: 11805843
  18. Seven-transmembrane-spanning receptors and heart function.
    Nature. 2002 Jan 10;415(6868):206-12 PMID: 11805844
  19. Cardiac channelopathies.
    Nature. 2002 Jan 10;415(6868):213-8 PMID: 11805845
  20. Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer.
    Circulation. 2002 Jan 29;105(4):502-8 PMID: 11815435
  21. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity.
    Cardiovasc Res. 2002 Feb 1;53(2):382-91 PMID: 11827689
  22. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy.
    J Clin Invest. 2002 Feb;109(3):357-62 PMID: 11827995
  23. Congenital heart disease caused by mutations in the transcription factor NKX2-5.
    Science. 1998 Jul 3;281(5373):108-11 PMID: 9651244
  24. Reduced Ca(2+)-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation.
    J Mol Cell Cardiol. 1999 Mar;31(3):479-91 PMID: 10198180
  25. Stress pathways and heart failure.
    Cell. 1999 Sep 3;98(5):555-8 PMID: 10490095
  26. Electrophysiological remodeling in hypertrophy and heart failure.
    Cardiovasc Res. 1999 May;42(2):270-83 PMID: 10533566
  27. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy.
    Cell. 1999 Oct 29;99(3):313-22 PMID: 10555147
  28. Gbetagamma-dependent phosphoinositide 3-kinase activation in hearts with in vivo pressure overload hypertrophy.
    J Biol Chem. 2000 Feb 18;275(7):4693-8 PMID: 10671499
  29. Prospects for gene therapy for heart failure.
    Circ Res. 2000 Mar 31;86(6):616-21 PMID: 10746995
  30. GATA-dependent recruitment of MEF2 proteins to target promoters.
    EMBO J. 2000 May 2;19(9):2046-55 PMID: 10790371
  31. Genomic circuits and the integrative biology of cardiac diseases.
    Nature. 2000 Sep 14;407(6801):227-32 PMID: 11001065
  32. A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages.
    Cell. 2000 Sep 1;102(5):671-82 PMID: 11007485
  33. Decoding calcium signals involved in cardiac growth and function.
    Nat Med. 2000 Nov;6(11):1221-7 PMID: 11062532
  34. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles.
    Circ Res. 2000 Dec 8;87(12):E61-8 PMID: 11110780
  35. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo.
    Circ Res. 2001 Jan 19;88(1):88-96 PMID: 11139479
  36. Cytoplasmic signaling pathways that regulate cardiac hypertrophy.
    Annu Rev Physiol. 2001;63:391-426 PMID: 11181961
  37. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43.
    Circ Res. 2001 Feb 16;88(3):333-9 PMID: 11179202
  38. Molecular and cellular mechanisms of cardiac arrhythmias.
    Cell. 2001 Feb 23;104(4):569-80 PMID: 11239413
  39. Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo.
    Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3322-7 PMID: 11248077
  40. Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo.
    Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3328-33 PMID: 11248078
  41. A novel role for STAT3 in cardiac remodeling.
    Trends Cardiovasc Med. 2000 Oct;10(7):298-303 PMID: 11343970
  42. Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle.
    J Physiol. 2001 May 15;533(Pt 1):119-25 PMID: 11351020
  43. Oncogenic kinase signalling.
    Nature. 2001 May 17;411(6835):355-65 PMID: 11357143
  44. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis.
    Hum Mol Genet. 2001 May 15;10(11):1215-20 PMID: 11371514
  45. Characterization of homo- and heterodimerization of cardiac Csx/Nkx2.5 homeoprotein.
    J Biol Chem. 2001 Feb 16;276(7):4570-80 PMID: 11042197
  46. Evidence that human cardiac myocytes divide after myocardial infarction.
    N Engl J Med. 2001 Jun 7;344(23):1750-7 PMID: 11396441
  47. Activation of cardiac c-Jun NH(2)-terminal kinases and p38-mitogen-activated protein kinases with abrupt changes in hemodynamic load.
    Hypertension. 2001 May;37(5):1222-8 PMID: 11358932
  48. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.
    Cell. 2000 May 12;101(4):365-76 PMID: 10830164
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
DOI
10.1172/JCI15380
Published
2002-04-00
Pages
849-55
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC150934
Subset
IM
External Links
PubMed source DOI: 10.1172/JCI15380 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2